Expleo Solutions Director Bastien Georges Andre Lefranc appointed
Expleo Solutions (BSE: EXPLEOSOL) said Bastien Georges Andre Lefranc, Director, has been appointed. The company is valued at about ₹1,317 crore.
What happened
Expleo Solutions (BSE: EXPLEOSOL) informed the stock exchanges on 14 November 2026 at 03:59 PM that Bastien Georges Andre Lefranc, Director, has been appointed.
From the filing: "The Board of Directors at their meeting held on November 14, 2026 approved the appointment of Mr."
Company snapshot
Expleo Solutions is a small-cap company, with a market value of about ₹1,317 crore.
The stock last traded at ₹848.6, against a 52-week range of ₹640–₹1,175.1 (27.8% below the high).
Before this filing the shares had moved −3.7% over the month and +3.3% over three months. Average daily turnover over the last 20 sessions was about ₹1.35 crore.
Promoters held 71.05% at the end of Q1 FY27. Foreign institutions owned 0.13% and domestic institutions 0.12%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 260 | 20.4 | 13.16 |
| Q2 FY26 | 283 | 39.8 | 25.62 |
| Q3 FY26 | 279 | 22.1 | 14.26 |
| Q4 FY26 | 286 | 49.3 | 26.85 |
| Q1 FY27 | 292 | 34.2 | 22.02 |
What history shows
BCEIE's records show 5 previous management change filings from the company since May 2026.
After those filings, the stock gained 0.3% on average the next trading day and was up 0.8% on average after five days (4 filings with price data).
Market-wide, 4,556 management change filings with an impact score of 50 or more saw an average next-day move of −0.0%, with 46% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 19 Aug 2026 | Management change | −1.6% | −2.0% |
| 1 Aug 2026 | Update on last working day of Mr. Saket Newaskar, Key Managerial… | +1.4% | +4.1% |
| 3 Jul 2026 | Management change | +0.6% | +0.6% |
| 3 Jul 2026 | Resignation of Mr Saket Newaskar as Other of the company w.e.f. July… | +0.6% | +0.6% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 14 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.